Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Yung

Showing results (81-90 of 217) with videos related to

Pageof 22
Sort By:
Neuro-Oncology|July 10, 2010
Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label studyW K Alfred Yung, James J Vredenburgh, Timothy F Cloughesy, et al.
International Journal of Oncology|July 6, 2007
Activation of polyamine catabolism by N1,N11-diethylnorspermine leads to cell death in glioblastomaRongcai Jiang, Woonyoung Choi, Asad Khan, et al.
Acta Neuropathologica|September 2, 2015
Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastomaQun Liu, Yuexin Liu, Wenliang Li, et al.
Tetrahedron|August 12, 2014
Design and Synthesis of an Inositol Phosphate Analog Based on Computational Docking StudiesZhenghong Peng, David Maxwell, Duoli Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomasQi Zhao, Otavia L Caballero, Ian D Davis, et al.
Neuro-Oncology Advances|October 25, 2021
Results of a phase I trial to assess the safety of macitentan in combination with temozolomide for the treatment of recurrent glioblastomaShiao-Pei Weathers, Julie Rood-Breithaupt, John de Groot, et al.
Cancer Chemotherapy and Pharmacology|October 11, 2011
Pharmacokinetic drug interaction between AEE788 and RAD001 causing thrombocytopenia in patients with glioblastomaDavid A Reardon, Timothy Cloughesy, Jeremy Rich, et al.
Cancer Chemotherapy and Pharmacology|November 1, 2011
Ridaforolimus for patients with progressive or recurrent malignant glioma: a perisurgical, sequential, ascending-dose trialDavid A Reardon, Patrick Y Wen, W K Alfred Yung, et al.
Neuro-Oncology|February 17, 2010
Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastomaDimpy Koul, Ruijun Shen, Yong-Wan Kim, et al.
Journal of Pain and Symptom Management|August 1, 2006
Complementary and alternative medicine use and quality of life in patients with primary brain tumorsTerri Armstrong, Marlene Z Cohen, Kenneth R Hess, et al.
Pageof 22

Showing results (81-90 of 217) with videos related to

Sort By:
Pageof 22
Neuro-Oncology|July 10, 2010
Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label studyW K Alfred Yung, James J Vredenburgh, Timothy F Cloughesy, et al.
International Journal of Oncology|July 6, 2007
Activation of polyamine catabolism by N1,N11-diethylnorspermine leads to cell death in glioblastomaRongcai Jiang, Woonyoung Choi, Asad Khan, et al.
Acta Neuropathologica|September 2, 2015
Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastomaQun Liu, Yuexin Liu, Wenliang Li, et al.
Tetrahedron|August 12, 2014
Design and Synthesis of an Inositol Phosphate Analog Based on Computational Docking StudiesZhenghong Peng, David Maxwell, Duoli Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomasQi Zhao, Otavia L Caballero, Ian D Davis, et al.
Neuro-Oncology Advances|October 25, 2021
Results of a phase I trial to assess the safety of macitentan in combination with temozolomide for the treatment of recurrent glioblastomaShiao-Pei Weathers, Julie Rood-Breithaupt, John de Groot, et al.
Cancer Chemotherapy and Pharmacology|October 11, 2011
Pharmacokinetic drug interaction between AEE788 and RAD001 causing thrombocytopenia in patients with glioblastomaDavid A Reardon, Timothy Cloughesy, Jeremy Rich, et al.
Cancer Chemotherapy and Pharmacology|November 1, 2011
Ridaforolimus for patients with progressive or recurrent malignant glioma: a perisurgical, sequential, ascending-dose trialDavid A Reardon, Patrick Y Wen, W K Alfred Yung, et al.
Neuro-Oncology|February 17, 2010
Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastomaDimpy Koul, Ruijun Shen, Yong-Wan Kim, et al.
Journal of Pain and Symptom Management|August 1, 2006
Complementary and alternative medicine use and quality of life in patients with primary brain tumorsTerri Armstrong, Marlene Z Cohen, Kenneth R Hess, et al.
Pageof 22